* GEMACBIO *
1999 - Aquitaine
Berganton, Saint Jean d’Illac
(near Bordeaux)
www.gemacbio.com Development, Diagnostics
(also, Contract, Manufacturing)
Key words: Antibodies, Customization, CNS disorders, Auto-immune diseases
Mission: to develop a wide range of monoclonal and polyclonal antibodies against neurotransmitters, nitrosylated and nitrated amino-acids, bacterial antigens
Clients: Distributors, Pharmaceutical industry, Biotech, Research labs
info@gemacbio.com
Age: 10 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Personal venture |
Managing Dir.-CEO: Lurton (Louis) [born 1956]
Sc.Dir.-CSO:
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): IRDI, ACI, SOCRI, Oséo/Anvar, business angels | Turnover (M€) : 0.4 (2007)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : CNS
Position : Trade
Company confirm : 29-Sept-2009 |
History | DATE | MILESTONE | TYPE | TIME | | 2008 .01 | Company move from Cenon (Bordeaux eastern suburb) to Berganton, Saint Jean d’Illac, Southwest of Bordeaux | ORGL | [8 years] |
| 2006 .03 | Clinical trial (phase IIa) in Multiple Sclerosis diagnostic (completed) | CLIN | [6 years] |
| 1999 .12 | Company founded by Michel Geffard | ORGF | [0 year] | Actualisation / Updating: 29-Sept-2009 |
|
